Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
This study has been completed.
Study NCT00509873   Information provided by Allergan
First Received: July 30, 2007   Last Updated: July 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bacterial Conjunctivitis
Additional conditions recognized in this trial
Conjunctivitis
Conjunctivitis, Bacterial
More general conditions related to this trial
Bacterial Infections
Conjunctival Diseases
Eye Diseases
Eye Infections
Eye Infections, Bacterial
Infection
Interventions listed in this trial
Gatifloxacin 0.5% eye drops
placebo eye drops
Additional drug interventions recognized in this trial
Gatifloxacin
Tetrahydrozoline
More general drug interventions related to this trial
Anti-Infective Agents
Autonomic Agents
Cardiovascular Agents
Nasal Decongestants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services